Silk Road Medical Valuation
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
At this time, the company appears to be overvalued. Silk Road Medical has a current Real Value of $23.26 per share. The regular price of the company is $27.49. Our model measures the value of Silk Road Medical from inspecting the company fundamentals such as Return On Equity of -0.36, shares outstanding of 40.63 M, and Operating Margin of (0.34) % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Silk Road's price fluctuation is very steady at this time. Calculation of the real value of Silk Road Medical is based on 3 months time horizon. Increasing Silk Road's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Silk Road's intrinsic value may or may not be the same as its current market price of 27.49, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.49 | Real 23.26 | Hype 27.49 |
The intrinsic value of Silk Road's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Silk Road's stock price.
Estimating the potential upside or downside of Silk Road Medical helps investors to forecast how Silk stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Silk Road more accurately as focusing exclusively on Silk Road's fundamentals will not take into account other important factors: Silk Road Total Value Analysis
Silk Road Medical is at this time expected to have valuation of 1.02 B with market capitalization of 1.12 B, debt of 84.63 M, and cash on hands of 108.87 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Silk Road fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.02 B | 1.12 B | 84.63 M | 108.87 M |
Silk Road Investor Information
About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.45. Silk Road Medical had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Silk Road's historical financial statements, Silk Road Medical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Silk Road Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Silk Road has an asset utilization ratio of 66.77 percent. This suggests that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that Silk Road Medical is more efficient with each dollar of assets it utilizes for everyday operations.Silk Road Ownership Allocation
Silk Road Medical shows a total of 40.63 Million outstanding shares. The majority of Silk Road Medical outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Silk Road to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Silk Road Medical. Please pay attention to any change in the institutional holdings of Silk Road Medical as this could imply that something significant has changed or is about to change at the company. Also note that roughly six hundred fifty-four thousand one hundred seventy-seven invesors are currently shorting Silk Road expressing very little confidence in its future performance.Silk Road Profitability Analysis
The company reported the previous year's revenue of 177.13 M. Net Loss for the year was (55.74 M) with profit before overhead, payroll, taxes, and interest of 100.76 M.About Silk Road Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Silk Road Medical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Silk Road Medical based exclusively on its fundamental and basic technical indicators. By analyzing Silk Road's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Silk Road's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Silk Road. We calculate exposure to Silk Road's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Silk Road's related companies.Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.
Silk Road Growth Indicators
Investing in growth stocks can be very risky. If the company such as Silk Road does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 38.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets |